Cannabis-Related Healthcare Encounters Among Commercially Insured Adults Aged 18-64 years Contributing Data to the US Food and Drug Administration’s Sentinel, 2017-2022

The increasing number of United States (U.S.) state, local, tribal, and territorial bodies enacting laws allowing medical or both medical and nonmedical adult use of cannabis and the passage of the 2018 Farm Bill have paved the way for a booming cannabis market. Expanded access to cannabis among U.S. adults may potentially increase the public health burden from cannabis-related disorders and poisonings. 

This poster discusses a study that examined temporal trends in cannabis-related healthcare encounters among commercially insured U.S. adults, using administrative claims data from four national health insurers in the FDA’s Sentinel Distributed Database. It was presented at the 2025 ISPE Annual Meeting.